Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
about
Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models.Superior effects of quetiapine compared with aripiprazole and iloperidone on MK-801-induced olfactory memory impairment in female miceThe NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysisAntidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.Ketamine Strengthens CRF-Activated Amygdala Inputs to Basal Dendrites in mPFC Layer V Pyramidal Cells in the Prelimbic but not Infralimbic Subregion, A Key Suppressor of Stress ResponsesAlpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases.Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice.Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study.Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats.Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia.Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia.Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.
P2860
Q30407741-E6BB4BD0-2D1E-41D2-970C-F2A2BBBFE5F2Q33685248-DB551F7E-55F8-4D0A-ADAD-A9C7DD33C647Q33920257-8234C98C-F498-4C4A-B6B0-ABAAB7C923BFQ34458640-D776DBF5-1FFB-4C46-B1A6-244FC7763472Q35952277-A63AF6B8-11C4-458F-B953-11F176D7B7AAQ36096029-F1D1078D-6CEB-4A95-9DE8-44100BB8DB58Q36184922-60754FF1-E171-4545-A1F4-6DD461F8F080Q36243977-22584865-8FED-4B19-8167-AB23B73133F4Q36486035-2C5E5897-F28C-4ABA-B20C-9869C2CA1D72Q37172877-AC7876FE-5E9C-49D3-B806-85DEF2A9CF6CQ38187948-1EBD3D65-0F3D-4FEA-985E-8E675EA8EFE8Q38526546-A3C3E849-F9D1-46C6-9D8F-B577DF2D4678Q38618630-1840E54E-8A55-48F1-BD0D-8A5BCC744437Q38820476-9B20BA70-95EE-4267-A280-0B9E6F9F3ED1Q39169781-E02B4871-0FEF-4D57-A43B-B26297420AE4Q41449158-27B76876-BAFA-41AF-BCFB-0E7638372CDBQ41691255-11DE21BE-0872-412E-9B2C-B7C136C7D2C4Q45145553-356BC4EC-53B9-4EE3-A114-CBEA800295EFQ47557959-90F5AEBD-9605-4CF6-B429-05F2BB3CD578Q47669147-77DD6BFB-CCB4-401F-B3C2-C9A36D997438Q47824089-B2CA4C26-E8C2-44FC-93E4-E1FE3FBA4ED6Q47911078-04F40F19-8035-487F-9118-DDBBA0D4809DQ47925112-ADD750B5-4C6E-49A0-8752-936DA92F0F7DQ48827728-A4902CEE-C4AE-4EC6-A7E9-446E8401C5C7Q50488312-C182DFCA-EEBE-42CC-A724-8D8C3231674EQ50550002-9588794D-F697-47F8-964A-0839B1E5D582Q50576901-A3CE7EA0-ECEE-450E-99E2-9758B0864E93Q50590446-1D938338-67F7-4DA5-BC2D-E06E29DBF085Q52147043-E697B202-1B02-4613-8DFC-78D1F43240A1
P2860
Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Translating the N-methyl-D-asp ...... e impairment in schizophrenia.
@en
type
label
Translating the N-methyl-D-asp ...... e impairment in schizophrenia.
@en
prefLabel
Translating the N-methyl-D-asp ...... e impairment in schizophrenia.
@en
P2093
P2860
P1476
Translating the N-methyl-D-asp ...... e impairment in schizophrenia.
@en
P2093
Herbert Y Meltzer
Lakshmi Rajagopal
Masakuni Horiguchi
Sunoh Kwon
Yoshihiro Oyamada
P2860
P304
P356
10.1017/S1461145713000928
P577
2013-11-01T00:00:00Z